- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.94%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH and its peers as on 5 June, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 11.05% | 0.94% | 1.37% | 4.17% | 8.76% | 11.71% | 26.47% | 16.75% | 23.91% | 14.36% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -9.24% | -0.1% | -0.63% | -4.63% | -3% | -8.84% | 8.63% | 13.56% | 14.61% | 14.68% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -7.31% | -0.06% | -1.02% | -1.4% | -2.89% | -2.78% | 10.46% | 10.34% | 11.87% | 12.27% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.05% | 0.2% | -0.94% | -1.29% | 5.89% | 2.35% | 19.65% | 19.21% | 18.38% | 16.36% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 2.19% | -0.36% | -0.58% | -3.57% | -4.12% | 9.51% | 30.23% | 24.22% | 19.24% | 16.21% |
| SBI TECHNOLOGY OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -18.9% | -0.72% | -0.83% | -0.31% | -1.31% | -12.4% | 9.71% | 10.97% | 17.14% | 15.79% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.62% | 2.71% | -8.64% | 0.65% | 68.71% | 20.05% | -4.78% | 40.03% | 43.86% | -2.89% |
Discrete returns (monthly)
| Month | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.12% | -1.93% | 2.61% | 0.63% | -2.82% | -3.5% | 6.36% | -3.54% | 5.89% | 4.65% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 17.38% | 7.47% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.16% | 0.07% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.77% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.11% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.59% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 5.67% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.48% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.97% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.10% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.96% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.74% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 3.56% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 3.33% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.17% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.16% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.93% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.93% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 2.84% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.61% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.57% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.50% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 2.45% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.24% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.07% |
| Sudeep Pharma Ltd. | INE0QPI01025 | Pharmaceuticals & Biotechnology | 1.98% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.91% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.88% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.80% |
| Nephrocare Health Service Pvt. Ltd. | INE428V01029 | Healthcare Services | 1.00% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.89% |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.63% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.54% |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 0.53% |
| Medplus Health Services Ltd. | MEDPLUS (INE804L01022) | Retailing | 0.41% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.35% |
| Corona Remedies Ltd. | INE02ZQ01018 | Pharmaceuticals & Biotechnology | 0.29% |
| Lonza Group | US54338V1017 | Pharmaceuticals & Biotechnology | 2.97% |
Debt
| Name | Rating | Weight % |
|---|---|---|
| 364 DAY T-BILL 19.11.26 | Sovereign | 0.07% |
Portfolio data is as on date 31 March, 2026
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 5 June, 2026 | 537.8663 | 0.94% |
| 4 June, 2026 | 532.8558 | 0.47% |
| 3 June, 2026 | 530.3589 | 0.7% |
| 2 June, 2026 | 526.6839 | -0.11% |
| 1 June, 2026 | 527.2899 | -0.62% |
| 31 May, 2026 | 530.5772 | 0% |
| 29 May, 2026 | 530.5996 | -0.81% |
| 27 May, 2026 | 534.9391 | -0.47% |
| 26 May, 2026 | 537.4877 | -0.1% |
| 25 May, 2026 | 538.0219 | -0.09% |
| 22 May, 2026 | 538.4936 | -0.93% |
| 21 May, 2026 | 543.5384 | 0.72% |
| 20 May, 2026 | 539.6701 | 0.12% |
| 19 May, 2026 | 539.0277 | 0.6% |
| 18 May, 2026 | 535.8392 | 0.6% |
| 15 May, 2026 | 532.6382 | -0.27% |
| 14 May, 2026 | 534.0602 | 1.17% |
| 13 May, 2026 | 527.9082 | 0.37% |
| 12 May, 2026 | 525.9604 | -1.36% |
| 11 May, 2026 | 533.1953 | 0.97% |
| 8 May, 2026 | 528.0947 | 0.36% |
| 7 May, 2026 | 526.2109 | 0.29% |
| 6 May, 2026 | 524.6682 | 1.61% |
| 5 May, 2026 | 516.3356 | 0.08% |
| 4 May, 2026 | 515.9181 | 1.76% |
| 30 April, 2026 | 507.0144 | 0.23% |
| 29 April, 2026 | 505.8588 | 0.31% |
| 28 April, 2026 | 504.2791 | -0.27% |
| 27 April, 2026 | 505.6352 | 2.76% |
| 24 April, 2026 | 492.0527 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 537.8663 as on 5 June, 2026.What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 11.05% as on 5 June, 2026.What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 11.71% as on 5 June, 2026.What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 26.47% as on 5 June, 2026.What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.75% as on 5 June, 2026.What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.75% as on 5 June, 2026.